Deciphera Pharmaceuticals Inc. (DCPH) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Thu May 13th, 2021

- 10:23
  AnalysisNear a 2-Year Low, Is Deciphera Pharmaceuticals a Buy?The Motley Fool

Mon May 10th, 2021

- 04:25
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. (DCPH) CEO Steven Hoerter on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha

Wed May 5th, 2021

- 11:30
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. (DCPH) Q1 2021 Earnings Call TranscriptThe Motley Fool

Thu February 18th, 2021

- 06:53
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDeciphera's Ripretinib In 2nd Line GIST: An AssessmentSeeking Alpha

Wed February 10th, 2021

- 15:21
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDeciphera (DCPH) Reports Narrower-Than-Expected Q4 LossZacks
- 09:34
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call PresentationSeeking Alpha
- 03:20
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. (DCPH) CEO Steven Hoerter on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha
- 03:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. (DCPH) Q4 2020 Earnings Call TranscriptThe Motley Fool

Tue February 9th, 2021

- 22:15
  AnalysisDeciphera Pharmaceuticals, Inc. (DCPH) Reports Q4 Loss, Tops Revenue EstimatesZacks + 5 more

Wed January 20th, 2021

- 20:29
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDeciphera Pharmaceuticals (DCPH) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowSeeking Alpha

Fri December 18th, 2020

- 17:14
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: BioMarin Pharmaceutical, uniQure, REGENXBIO and Deciphera PharmaceuticalsZacks

Thu December 3rd, 2020

- 14:17
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDeciphera Pharmaceuticals started at buy with $75 stock price target at Stifel NicolausMarketWatch

Tue December 1st, 2020

- 15:04
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDeciphera (DCPH) Ends Qinlock Second-Line GIST Study EnrollmentZacks

Mon November 9th, 2020

- 15:18
  AnalysisDeciphera (DCPH) Reports Narrower-Than-Expected Loss in Q3Zacks

Sun November 8th, 2020

- 10:38
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Sat November 7th, 2020

- 03:31
  EarningsAnalysisDeciphera Pharmaceuticals, Inc. (DCPH) Q3 2020 Earnings Call TranscriptThe Motley Fool

Fri November 6th, 2020

- 13:00
  Press ReleasesMedison Pharma Enters Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize QINLOCK® (Ripretinib) in a Multi-Regional AgreementPR Newswire

Sun August 9th, 2020

- 20:02
  AnalysisDigestWeek In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 VaccineSeeking Alpha

Wed August 5th, 2020

Tue August 4th, 2020

- 22:25
  AnalysisDeciphera Pharmaceuticals, Inc. (DCPH) Reports Q2 Loss, Tops Revenue EstimatesZacks + 7 more

Mon May 18th, 2020

- 16:22
  AnalysisDeciphera (DCPH) Secures Early FDA Nod for GIST Drug QinlockZacks

SPY$395.63-3.6%

QQQ$315.85-1.1%

DOW$64.14-5.8%

--

SPY$395.63-3.6%

QQQ$315.85-1.1%

DOW$64.14-5.8%

--

About Developer Contact